Shamik Parikh
Vermögen: 354 527 $ am 31.05.2026
Vermögen: 354 527 $ am 31.05.2026
Shamik J.
Parikh is currently Chief Medical Officer at Humacyte, Inc. since 2022.
Formerly, Dr. Parikh was Vice President & Head-Patient Safety Center at AstraZeneca PLC from 2016 to 2022 and Director-Clinical Development & Medical Affairs at GlaxoSmithKline LLC from 2003 to 2005.
Education includes a doctorate from Topiwala National Medical College & BYL Nair.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HUMACYTE, INC. 0,12 % | 18.05.2026 | 272.713 ( 0,12 % ) | 354 527 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HUMACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.04.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2022 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01.06.2005 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Topiwala National Medical College & BYL Nair
Topiwala National Medical College & BYL Nair Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humacyte, Inc.
Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen